Pancreatic Cancer Research

Clinical trialPhase 2Recruiting

Stereotactic Body Radiotherapy and NALIRIFOX for Locally Advanced Pancreatic Cancer

Stereotactic Body Radiotherapy and NALIRIFOX for Locally Advanced Pancreatic Cancer: A Prospective Clinical Trial

NCT07173387↗ ClinicalTrials.gov, retrieved 4 November 2026

Outcome
Ongoing
Phase
Phase 2
Status
Recruiting
Study type
Interventional
Start
1 October 2025
Expected end
31 December 2028
Enrollment
42 participants
Sites
1
Primary outcomes
Progression-Free Survival
Sponsor
Other
Results posted
No
Last update
13 October 2026

These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.

Try

Papers 12